Skip to main content
C

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,245 across all filing types
Latest filing 2021-01-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
独立董事关于第四届董事会第三十一次会议相关事项的独立意见
Regulatory Filings
2021-01-26 Chinese
关于2020年年度业绩预告的补充公告
Regulatory Filings
2021-01-26 Chinese
关于终止筹划发行H股股票事项并撤回申请文件的公告
Regulatory Filings
2021-01-26 Chinese
第四届监事会第二十七次会议决议公告
Regulatory Filings
2021-01-26 Chinese
第四届董事会第三十一次会议决议公告
Regulatory Filings
2021-01-26 Chinese
2020年年度业绩预告
Regulatory Filings
2021-01-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.